
Dasamaps 50 Tablet
Marketer
AMPS Biotech Pvt Ltd
Salt Composition
Dasatinib (50mg)
Overview Dasamaps 50 Tablet
Dasamaps 50mg tablets are indicated for treating chronic myeloid leukemia (CML), specifically in patients unresponsive to, or intolerant of, alternative leukemia therapies. This medication may be ingested with or without food, but consistent daily timing optimizes its effectiveness. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Adhere strictly to the prescribed regimen; improper use or overdose can lead to severe adverse reactions. Therapeutic benefits may not be apparent for weeks or months; discontinue only under your doctor's direction. Common side effects include nausea, vomiting, abdominal pain, and rash. Increased heart rate and abnormal blood pressure (both high and low) are possible; consult your doctor immediately if these occur. Regular blood pressure monitoring may be necessary. Avoid antacids within two hours of administration. This medication can decrease blood cell counts, raising infection risk; regular blood tests are crucial. Inform your healthcare provider of all other medications you're taking, as interactions are possible. This medicine is contraindicated during pregnancy and breastfeeding. Refrain from driving if dizziness or blurred vision develops.
Uses of Dasamaps 50 Tablet
Chronic myelogenous leukemia, a type of blood malignancy
Major Benefits of Dasamaps 50 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Dasamaps 50 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.
Common Side effects of Dasamaps 50 Tablet:
- Abdominal pain
- Anemia (low number of red blood cells)
- Breathing problems
- Fatigue
- Fever
- Headache
- Infection
- Low blood platelets
- Musculoskeletal (bone, muscle or joint) pain
- Nausea
- Rash
- Vomiting
How to use Dasamaps 50 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dasamaps 50 Tablet can be consumed with or without food, though consistent timing is recommended.
How Dasamaps 50 Tablet works:
Dasamaps 50 Tablet is an anti-neoplastic agent. Its mechanism of action involves inhibiting the activity of a faulty protein responsible for triggering cancer cell proliferation. This consequently arrests or retards cancerous growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Dasamaps 50 Tablet lacks established safety data. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Use of Dasamaps 50 Tablet is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Lactation and Dasamaps 50 Tablet are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Dasamaps 50 Tablet side effects. Exercise caution while driving if you experience dizziness or blurred vision after taking Dasamaps 50 Tablet.
KidneySAFE IF PRESCRIBED
Use of Dasamaps 50 Tablet in patients with kidney disease appears to be safe. Existing evidence indicates dose modification may not be necessary, however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Dasamaps 50 Tablets pose no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Dasamaps 50 Tablet :
Omit any missed Dasamaps 50 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Dasamaps 50 Tablet
| Label | Value |
|---|---|
| Chemical Category | Pyrimidine and Thiazole Derivatives |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | Kinase inhibitors targeting tyrosine |
